|
Carcinoma, Islet Cell
|
C06.689.667.500 |
|
|
Conservation of Natural Resources
|
J01.256 |
|
|
Psychiatric Department, Hospital
|
N02.278.216.500.968.641 |
|
|
Vascular Endothelial Growth Factor, Endocrine-Gland-Derived
|
D23.529.100.800.600 |
|
|
Vascular Endothelial Growth Factors
|
D23.529.100.800 |
|
|
Compomers
|
D05.750.716.822.308.300 |
|
|
Drug Design
|
E05.290.500 |
|
|
Drug Development
|
E05.290 |
|
|
Trustees
|
N04.452.394.600 |
|
|
Governing Board
|
N04.452.394 |
|
|
Intraoperative Awareness
|
C23.550.505.400 |
|
|
Clofarabine
|
D13.570.065.195 |
|
|
Ganglioside Galactosyltransferase
|
D08.811.913.400.450.400.475 |
|
|
Sezary Syndrome
|
C20.683.515.761.480.750.800.775 |
|
|
Sp3 Transcription Factor
|
D12.776.260.522.750.750 |
|
|
Lymphoma, B-Cell
|
C04.557.386.480.150 |
|
|
Lymphoma, Non-Hodgkin
|
C04.557.386.480 |
|
|
Chemokine CCL7
|
D12.776.467.374.200.110.990.800 |
|
|
Multivariate Analysis
|
N06.850.520.830.150.500 |
|
|
Analysis of Variance
|
N06.850.520.830.150 |
|
